Very Happy to see the OUTBACK trial finally in print! Many thanks to all that made this happen
Adjuvant chemotherapy following chemoradiotherapy as primary treatment... https://t.co/VxUToL0rhc @PeterMacCC@anzgog@MartinStockler@TrialsCentre@YChenLee@pixiepk1
Thanks to our chemo suite nurses, who work hard to deliver the best care to our patients, but we don't have enough staff-POWH Randwick. The LHD needs to see this. #nursingshortage#cancercare@SEastSydHealth
The wonderful nurses https://t.co/wBMXF2jJI9 via @careopinionau
What a whirlwind the last 3 days have been at the #ANZGOG2023ASM. It was inspirational, collegiate and best of all full of smiles and laughs. Can’t wait to do it again next year. A massive shout out to our whole amazing @anzgog team who enable the research we undertake.
Fantastic talk by @RParejaGineOnco at #ANZGOG2023ASM highlighting what really matters in the surgical management of cervix cancer - reminding all that most cases occur in LMICS @AndreasObermair
NHMRC Ideas Grants are the primary funding source for early to mid-career researchers & their work. However in 2022 the majority went to established, senior researchers. We need to fix this in the upcoming Federal Budget. Watch our new animation outlining this critical issue 👇
REMINDER - ANZGOG ASM 2023 Earlybird registration ends in 2 weeks ⏰
In Brisbane, 22-24 March 2023, the theme is “Improving the lived experience of patients with gynaecological cancers".
Register before 1 Feb to receive early bird prices: https://t.co/TjaqbavjID
Proud to publish this meta-analysis of #ICI in #dMMR#endometrialcancer •Single-agent ICI is associated with a 5.74 times greater objective response in dMMR versus pMMR EC.
•42% reduction in risk of disease progression or death in dMMR versus pMMR EC. https://t.co/Nw4p1p1V5o
World-renowned thoracic oncologists Pyng Lee, Chee Lee & @HegiFiona were named #WCLC23 co-chairs & together with @IASLC will plan the annual research meeting, select program track members/meeting content & serve as ambassadors for attending international oncologists in Singapore.
#TOGAASM21 incl great learning opportunities
Q&A multidisciplinary panel chaired by @MichaelBoyer1 discussing changes due to potential intro of IO in early-stage NSCLC
MDT Masterclass chaired by @Mal_Itchins & @DasanthaJ discussing 3 cases
Register https://t.co/WaSh52BaKC
#LCSM
Brilliant way to guide treatment & avoid toxicity of chemotherapy using liquid biopsy. Stage 2 colon cancer has made a start. We should think about other cancers too! #ASCO22 https://t.co/oV9O01vGl3